http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7082195

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 597
issn 0066-4804
1098-6596
issueIdentifier 3
pageRange 590-597
publicationName Antimicrobial Agents and Chemotherapy
startingPage 590
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892
bibliographicCitation Sokal EM, Roberts EA, Mieli-Vergani G, McPhillips P, Johnson M, Barber J, Dallow N, Boxall E, Kelly D. A Dose Ranging Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of Lamivudine in Children and Adolescents with Chronic Hepatitis B. Antimicrob Agents Chemother. 2000 Mar;44(3):590–7. doi: 10.1128/aac.44.3.590-597.2000.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7eb8153065d3442061f00f8b88803bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7aac3c6a2036b4091a6fb9a0c95455bc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a76d8f683e912d79da0840c1549aa1a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2c1896ec8b03ce17f98163fcf55e0be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15b5ca406b2489afb5f4636dd3a57689
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e06df11bf076918506236dd007d2280f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63dc8a49a8db1fee5a85a5ef84c585fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02acc0f131af305bb16d2b6a606f4eda
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37a04b6e631385c0a34773a790faf42f
date 200003
identifier https://pubmed.ncbi.nlm.nih.gov/10681323
https://pubmed.ncbi.nlm.nih.gov/PMC89731
https://doi.org/10.1128/aac.44.3.590-597.2000
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686
https://portal.issn.org/resource/ISSN/0066-4804
https://portal.issn.org/resource/ISSN/1098-6596
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A Dose Ranging Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of Lamivudine in Children and Adolescents with Chronic Hepatitis B
discusses http://id.nlm.nih.gov/mesh/M0006695
http://id.nlm.nih.gov/mesh/M0028682
http://id.nlm.nih.gov/mesh/M0001518
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019259Q000493
http://id.nlm.nih.gov/mesh/D019694Q000188
http://id.nlm.nih.gov/mesh/D019259Q000627
http://id.nlm.nih.gov/mesh/D000998Q000627
http://id.nlm.nih.gov/mesh/D000998Q000493
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006515Q000302
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D019694Q000821
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004279Q000097
http://id.nlm.nih.gov/mesh/D019259Q000008
http://id.nlm.nih.gov/mesh/D000998Q000008
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D019259Q000009
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D006515Q000235
http://id.nlm.nih.gov/mesh/D000998Q000009
http://id.nlm.nih.gov/mesh/D002675
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398

Showing number of triples: 1 to 56 of 56.